| Amount | Holding |
|---|---|
| 10.48% | UnitedHealth Group Inc |
| 8.63% | Eli Lilly and Co |
| 7.13% | Merck & Co Inc |
| 6.59% | Bristol-Myers Squibb Company |
| 5.96% | Thermo Fisher Scientific Inc |
| 5.63% | Cigna Corp |
| 5.57% | Zoetis Inc Class A |
| 4.51% | Anthem Inc |
| 4.17% | AbbVie Inc |
| 4.05% | Humana Inc |
| 4.04% | Allergan PLC |
| 3.96% | PerkinElmer Inc |
| 3.27% | McKesson Corp |
| 2.80% | Jazz Pharmaceuticals PLC |
| 2.79% | Regeneron Pharmaceuticals Inc |
| 2.65% | IQVIA Holdings Inc |
| 2.57% | PRA Health Sciences Inc |
| 2.44% | Abbott Laboratories |
| 2.33% | Alexion Pharmaceuticals Inc |
| 1.95% | Teleflex Inc |
| 1.89% | Centene Corp |
| 1.85% | Henry Schein Inc |
| 1.83% | HealthEquity Inc |
| 1.42% | Edwards Lifesciences Corp |
| 1.16% | AmerisourceBergen Corp |
Expense Ratio Rating
2 /10
Expense Rating
0 /10
Market Score
2 /10
Category Score
0 /10
Market Size
2 /10
$ICHCX Alternatives
12%
FI Score
- ichcx
- Mutual Fund
- Sector Equity
- Healthcare
Expenses: 1.50% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why ยป